Catabasis Pharma (CATB) Tops Q1 EPS by 3c

Catabasis Pharma (NASDAQ: CATB) reported Q1 EPS of ($0.61), $0.03 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M